Turner was elected to serve Texas' 18th Congressional in November 2024. Turner was diagnosed with Osteosarcoma, a form of bone cancer, in 2022. HOUSTON - Congressman and former Houston Mayor ...

Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in ...

Considering taking supplements to treat osteosarcoma? Below is a list of common natural remedies used to treat or reduce the symptoms of osteosarcoma. Follow the links to read common uses ...

About OS Therapies OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.

Key data will be presented from the Company’s Phase 2b clinical trial of OST-HER2 in the prevention of recurrent, fully resected, lung metastatic osteosarcoma. This data will be compared with a ...

Biosciences’ collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an exploratory clinical ...

About OS Therapies OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.

OST-HER2 is an immunotherapy for osteosarcoma using a HER2 bioengineered form of the bacteria Listeria monocytogenes to trigger a strong immune response against cancer cells expressing HER2.